Published in Thorax on March 03, 2006
Cough management: a practical approach. Cough (2011) 1.23
Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease. BMC Pulm Med (2008) 0.91
Airways disease: phenotyping heterogeneity using measures of airway inflammation. Allergy Asthma Clin Immunol (2007) 0.87
Inhaled corticosteroids: potency, dose equivalence and therapeutic index. Br J Clin Pharmacol (2015) 0.83
Effect of treatment guidelines on the initial management of idiopathic pulmonary fibrosis. Br J Clin Pharmacol (2010) 0.79
The effects of inhaled corticosteroids on growth in children. Open Respir Med J (2014) 0.79
Factors associated with the use of corticosteroids in the initial management of idiopathic pulmonary fibrosis. Pharmacoepidemiol Drug Saf (2010) 0.78
Methylprednisolone Pulse Treatment of Graves' Ophthalmopathy Is Not Associated with Secondary Adrenocortical Insufficiency. Eur Thyroid J (2015) 0.75
Lost in the mist: acute adrenal crisis following intranasal fluticasone propionate overuse. Case Rep Med (2010) 0.75
Secondary adrenal insufficiency after glucocorticosteroid administration in acute spinal cord injury: a case report. J Spinal Cord Med (2014) 0.75
Multiple Adverse Effects of Systemic Corticosteroids: A Case Report. J Clin Diagn Res (2015) 0.75
Large-Dose Glucocorticoid Induced Secondary Adrenal Insufficiency in Spinal Cord Injury. Ann Rehabil Med (2016) 0.75
Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture. Nutrients (2016) 0.75
The UK General Practice Research Database. Lancet (1997) 10.62
Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma. Br Med J (1972) 6.28
Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care (2004) 4.39
Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate. BMJ (2002) 4.29
Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child (2002) 3.35
Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy. Lancet (1967) 2.44
Adrenal function after prolonged corticosteroid therapy. Br Med J (1962) 1.99
Recovery of adrenal function after substitution of beclomethasone dipropionate for oral corticosteroids. Br Med J (1973) 1.86
Hypothalamic-pituitary-adrenal axis suppression associated with the use of inhaled fluticasone propionate. J Allergy Clin Immunol (1998) 1.77
Pituitary-adrenal function during corticosteroid therapy. Lancet (1963) 1.77
Symptomatic adrenal insufficiency during inhaled corticosteroid treatment. Arch Dis Child (2001) 1.57
Adrenal insufficiency from inhaled corticosteroids. Ann Intern Med (2004) 1.50
Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate. Eur Respir J (2002) 1.45
Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects. Thorax (2003) 1.19
Acute adrenal insufficiency associated with high dose inhaled steroids. BMJ (1992) 1.11
Adrenal failure in bronchial asthma. Br Med J (1973) 1.10
Acute adrenal insufficiency after discontinuation of inhaled corticosteroid therapy. Lancet (1992) 1.05
Acute adrenal insufficiency in a patient with asthma after changing from fluticasone propionate to budesonide. J Allergy Clin Immunol (1999) 0.94
Adrenal crisis due to inhaled steroids is underestimated. Arch Dis Child (2003) 0.92
Hypoglycemia due to adrenal suppression secondary to high-dose nebulized corticosteroid. Pediatr Pulmonol (2002) 0.87
Relative safety and efficacy of inhaled corticosteroids. J Allergy Clin Immunol (1998) 0.81
Corticosteroid withdrawal in asthma. Br Med J (1973) 0.80
Adrenal insufficiency in an adult on inhaled corticosteroids; recovery of adrenal function with inhaled nedocromil sodium. Ann Allergy Asthma Immunol (1998) 0.78
Molecular analysis of FRIGIDA, a major determinant of natural variation in Arabidopsis flowering time. Science (2000) 9.08
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86
Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet (2000) 5.66
Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet (1988) 4.85
Asthma, wheezing, and school absence in primary schools. Arch Dis Child (1989) 4.57
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet (2004) 3.89
Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Thorax (2001) 3.23
Recent advances in coeliac disease. Gut (2006) 3.20
Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. Eur Respir J (1989) 3.12
Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax (1987) 3.06
Physical map and organization of Arabidopsis thaliana chromosome 4. Science (1995) 3.05
Salbutamol and isoproterenol. A double-blind trial to compare bronchodilator and cardiovascular activity. N Engl J Med (1969) 2.99
The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax (2011) 2.76
An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods (1990) 2.72
Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ (1993) 2.70
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax (2006) 2.59
Cloned, Ia-restricted T cells that do not produce interleukin 4(IL 4)/B cell stimulatory factor 1(BSF-1) fail to help antigen-specific B cells. J Immunol (1987) 2.53
Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet (1990) 2.52
Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell (2001) 2.45
A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur J Immunol (1989) 2.33
Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study. BMJ (2008) 2.32
B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol (1995) 2.29
Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med (1995) 2.25
Assessment and management of asthma in an accident and emergency department. Thorax (1985) 2.21
Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ (1996) 2.19
Sudden death in asthma: discussion paper. J R Soc Med (1983) 2.13
Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol (1983) 2.10
Anomalous insertion of the medial meniscus of the knee. A case report. J Bone Joint Surg Am (1995) 2.06
What symptoms predict the bronchial response to histamine? Evaluation in a community survey of the bronchial symptoms questionnaire (1984) of the International Union Against Tuberculosis and Lung Disease. Int J Epidemiol (1989) 2.05
Further improvements on the phosphotriester synthesis of deoxyribooligonucleotides and the oligonucleotide directed site-specific mutagenesis of E. coli lipoprotein gene. Nucleic Acids Res (1983) 2.05
Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis. Proc Natl Acad Sci U S A (2001) 2.05
CD4+ T cells: specificity and function. Immunol Rev (1988) 2.04
Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment. Am J Respir Crit Care Med (1999) 2.02
Response to inhaled histamine and 24 hour sodium excretion. Br Med J (Clin Res Ed) (1986) 2.01
Bronchoprotective role for endogenous prostaglandin E2. Lancet (1995) 2.01
Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations. Genome Res (2000) 1.99
The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med (1984) 1.95
Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut (2004) 1.92
beta-adrenergic agonist resistance in normal human airways. Lancet (1977) 1.91
Estimation and repeatability of the response to inhaled histamine in a community survey. Thorax (1987) 1.85
Management of asthma in schools. Arch Dis Child (1987) 1.81
Clinical experience of lymphangioleiomyomatosis in the UK. Thorax (2000) 1.80
Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax (1982) 1.77
Rapid magnetic resonance quantification on the brain: Optimization for clinical usage. Magn Reson Med (2008) 1.73
Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiologic studies. Am Rev Respir Dis (1992) 1.73
Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network. Thorax (2005) 1.71
Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci U S A (2000) 1.69
Randomised placebo controlled trial of beta agonist dose reduction in asthma. Thorax (1999) 1.68
Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study. Thorax (2008) 1.68
The distribution of peak expiratory flow variability in a population sample. Am Rev Respir Dis (1989) 1.66
How patients use domiciliary oxygen. Br Med J (1978) 1.66
Quantitative assessment of bronchial beta-adrenoceptor blockade in man. Br J Clin Pharmacol (1979) 1.65
Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax (1983) 1.64
Comparison of PD20 with two alternative measures of response to histamine challenge in epidemiological studies. Eur Respir J (1993) 1.61
Description of 31 YAC contigs spanning the majority of Arabidopsis thaliana chromosome 5. Plant J (1997) 1.59
Dosage and delivery of nebulised beta agonists in hospital. Thorax (1983) 1.59
Attitudes and long-term adjustment of patients surviving cardiac arrest. Br Med J (1971) 1.57
Differential activation of cytokine genes in normal CD4-bearing T cells is stimulus dependent. Eur J Immunol (1989) 1.57
Tissue oxygenation, anemia, and perfusion in relation to wound healing in surgical patients. Ann Surg (1991) 1.57
Screening for visual impairment in elderly patients with hip fracture: validating a simple bedside test. Eye (Lond) (2005) 1.53
Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. Am Rev Respir Dis (1984) 1.52
Current opinion on treatment of asymptomatic retinal detachments. Eye (Lond) (2006) 1.50
Does routine child health surveillance reach children most at risk of accidental injury? J Public Health Med (1995) 1.49
Step 3 of the asthma guidelines. Thorax (1999) 1.48
Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol. Clin Sci (Lond) (1981) 1.46
Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Scand J Gastroenterol (2004) 1.42
Quantitation of human immunodeficiency virus type 1 in breast milk. J Clin Microbiol (2003) 1.42
Guillain-Barre syndrome associated with Campylobacter infection. Br Med J (Clin Res Ed) (1982) 1.42
Implantable, polymeric systems for modulated drug delivery. Adv Drug Deliv Rev (2002) 1.42
General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart (2005) 1.41
Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo. Am Heart J (1982) 1.39
Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum Mol Genet (1997) 1.39
Exacerbations of asthma--still room for improvement. Lancet (2001) 1.39
Bronchodilator drugs. Pharmacol Ther (1982) 1.39
Asthma induced by suggestion: is it due to airway cooling? Am Rev Respir Dis (1984) 1.38
Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax (2001) 1.38
Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am Rev Respir Dis (1993) 1.37
Active parental consent in school-based research. An examination of ethical and methodological issues. Eval Rev (1996) 1.34
Airway and metabolic resistance to intravenous salbutamol: a study in normal man. Clin Sci (Lond) (1980) 1.33
Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Thorax (1988) 1.32
Assessment of bronchial beta blockade after oral bevantolol. Clin Pharmacol Ther (1981) 1.32
Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax (2004) 1.32
Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis (1991) 1.30
The impact of the 2004 NICE guideline and 2003 General Medical Services contract on COPD in primary care in the UK. QJM (2008) 1.30
High-dose inhaled albuterol in severe chronic airflow limitation. Am Rev Respir Dis (1988) 1.30
Fracture experience of patients with coeliac disease: a population based survey. Gut (2003) 1.30
Assessing change in airway calibre--measurement of airway resistance. Br J Clin Pharmacol (1979) 1.29
Tubulin is phosphorylated at tyrosine by pp60c-src in nerve growth cone membranes. J Cell Biol (1990) 1.28
Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther (2005) 1.27